# Bundibugyo virus

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/bundibugyo-virus-company
Canonical HTML page: https://getyourbrief.com/entity/bundibugyo-virus-company

## Timeline

- **2026-08-20**: WHO announces 70,000-dose Ervebo allocation — The World Health Organisation said Congo will receive 70,000 doses of Ervebo, with 20,000 for a phase 3 clinical trial and 50,000 for front-line and health workers.
- **2026-08-04**: High-level international visits — WHO Director-General Tedros Adhanom Ghebreyesus arrives in Kinshasa; Africa CDC head Jean Kaseya visits Bunia, warning that 80% of cases are from community spread.
- **2026-08-03**: Healthcare workers' ultimatum — Healthcare workers in Mongbwalu issue a 24-hour ultimatum over unpaid wages, threatening escalation.
- **2026-07-27**: 3,000 Cases Milestone — Total cases reach 3,075, with 1,354 deaths, amid healthcare strikes and calls for accelerated countermeasure development.
- **2026-07-25**: Elikya Treatment Center strike — About 100 health workers at the Elikya Ebola Treatment Center in Bunia strike over unpaid bonuses, paralyzing patient care.
- **2026-07-25**: Elikya Treatment Center strike — About 100 health workers at the Elikya Ebola Treatment Center in Bunia strike over unpaid bonuses, paralyzing patient care.
- **2026-07-24**: Government releases updated data — Congo's Ministry of Health confirms 2,973 cases and 1,309 deaths, the fastest-growing outbreak on record.
- **2026-07-24**: Government releases updated data — Congo's Ministry of Health confirms 2,973 cases and 1,309 deaths, the fastest-growing outbreak on record.
- **2026-07-24**: First Experimental Vaccine Volunteer Dosed — Oxford University reports that the first volunteer group has received its candidate vaccine specifically targeting Bundibugyo.
- **2026-07-18**: Strike at Bunia General Hospital — Health workers at the region's largest hospital strike over unpaid salaries, stating they have not been paid since the outbreak started.
- **2026-07-18**: Strike at Bunia General Hospital — Health workers at the region's largest hospital strike over unpaid salaries, stating they have not been paid since the outbreak started.
- **2026-07-15**: 2,000 Cases Surpassed — Cumulative confirmed cases exceed 2,000, with rapid spread noted in conflict zones.
- **2026-07-10**: Record outbreak data confirmed — Africa CDC reports the outbreak as the fastest-growing ever at 1,830 confirmed cases and 648 deaths. U.S. aid worker infection announced by CDC.
- **2026-07-10**: Record outbreak data confirmed — Africa CDC reports the outbreak as the fastest-growing ever at 1,830 confirmed cases and 648 deaths. U.S. aid worker infection announced by CDC.
- **2026-07-06**: Clinical trials for treatments launched — Researchers initiate a highly anticipated clinical study to test experimental therapies against the Bundibugyo virus.

## Recent coverage (9 stories, network-wide)

### DRC receives 70,000 Ebola vaccine doses as outbreak deaths hit 2,476
2026-08-20 18:55:43 · Sector: health · Sentiment: Positive · Impact: 6/10 · Sources: 2

The WHO will send 70,000 Ervebo doses to DRC, with 50,000 prioritized for health workers and 20,000 used in a Phase 3 trial. The current Bundibugyo outbreak has killed 2,476 of 5,208 confirmed cases, and most new cases are outside monitored contacts.
Full story: https://gethealthbrief.com/story/drc-70000-ebola-vaccine-outbreak-health-response

### Ebola Kills 2,300+ as Mobile Miners Evade Congo Health Workers
2026-08-19 09:07:01 · Sector: health · Sentiment: Negative · Impact: 6/10 · Sources: 3

Eastern Congo's Bundibugyo Ebola outbreak has passed 2,300 deaths among at least 5,000 cases, and mobile artisanal gold miners are undermining containment. Health workers face unmonitored populations, unsafe sites, and no approved countermeasures for this Ebola species.
Full story: https://gethealthbrief.com/story/ebola-mobile-miners-congo-health-surveillance

### Bundibugyo Ebola: 5,000+ Cases, No Approved Vaccine in Congo
2026-08-19 09:06:53 · Sector: bio · Sentiment: Negative · Impact: 6/10 · Sources: 3

The current Ebola outbreak in eastern Congo is caused by Bundibugyo virus, a less common species with no approved treatment or vaccine. With 5,000+ cases and 2,300+ deaths, it reveals a critical gap in filovirus countermeasure development and rapid-response platforms.
Full story: https://getbiobrief.com/story/bundibugyo-ebola-outbreak-congo-no-vaccine

### Ebola Outbreak: 80% Community Spread Exposes Contact Tracing Collapse in DRC
2026-08-04 15:23:42 · Sector: health · Sentiment: Strongly negative · Impact: 8/10 · Sources: 2

The Bundibugyo Ebola outbreak in DRC has killed 1,700 people as community transmission drives 80% of new cases, revealing critical gaps in digital contact tracing and surveillance. With no approved vaccines, health IT innovators face an urgent call to deploy mobile tracing, AI analytics, and rapid diagnostics. Ongoing clinical trials may offer hope, but the immediate need is for tech-enabled outbreak management.
Full story: https://gethealthbrief.com/story/ebola-congo-health-it-failure

### Ebola Outbreak Tops 3,000 Cases, Oxford Starts Clinical Trial for Bundibugyo Vaccine
2026-07-27 09:57:21 · Sector: bio · Sentiment: Strongly negative · Impact: 7/10 · Sources: 2

DRC’s 17th Ebola outbreak has exploded to 3,075 cases and 1,354 deaths, with 1,000 new infections in just 10 days. The Bundibugyo strain has no approved vaccine or treatment, igniting a biotech race: Oxford University has dosed its first volunteer with an experimental vaccine, while other candidates are fast-tracked, creating high-stakes opportunities for pharma developers.
Full story: https://getbiobrief.com/story/ebola-outbreak-3000-cases-bundibugyo-vaccine-clinical-trial

### Bundibugyo Ebola Hits 2,973 Cases, 1,309 Deaths: A Biotech Call to Arms
2026-07-25 13:34:07 · Sector: bio · Sentiment: Strongly negative · Impact: 8/10 · Sources: 2

The Bundibugyo virus outbreak is the fastest-growing on record, with a 44% case fatality rate and no approved vaccine or therapy. Biopharma companies and researchers face a critical test as containment fails and the need for medical countermeasures becomes more urgent.
Full story: https://getbiobrief.com/story/bundibugyo-ebola-outbreak-2973-biotech

### 2,973 Ebola Cases, 1,309 Deaths: Health Worker Strikes Paralyze Congo Response
2026-07-25 13:32:28 · Sector: health · Sentiment: Strongly negative · Impact: 8/10 · Sources: 2

The strike at Bunia's Ebola treatment centers due to unpaid wages is crippling the response to the rapidly spreading Bundibugyo outbreak, with over 100 health workers already infected. Healthcare professionals globally must take note of the operational and safety failures that threaten containment efforts.
Full story: https://gethealthbrief.com/story/ebola-health-worker-strike-2973-cases

### Fastest-Growing Ebola Outbreak: 1,830 Cases, US Aid Worker Infected in Congo
2026-07-23 23:44:04 · Sector: health · Sentiment: Strongly negative · Impact: 8/10 · Sources: 2

The record Ebola outbreak in Congo surpasses 1,830 cases and 648 deaths, with a second U.S. humanitarian worker now infected. The public health response faces severe funding and security obstacles, while experimental treatments enter clinical trials.
Full story: https://gethealthbrief.com/story/ebola-outbreak-us-aid-worker-infected-record-cases

### Bundibugyo Ebola Outbreak at 1,830 Cases Spurs Urgent Clinical Trials
2026-07-23 23:43:52 · Sector: bio · Sentiment: Strongly negative · Impact: 8/10 · Sources: 2

With no approved vaccine or treatment, the rare Bundibugyo ebolavirus driving the Congo outbreak has infected 1,830 people and killed 648. As two U.S. workers fall ill, recently launched clinical trials represent the only hope for a therapeutic breakthrough.
Full story: https://getbiobrief.com/story/bundibugyo-ebola-outbreak-clinical-trials-begin

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.